Pretražite po imenu i prezimenu autora, mentora, urednika, prevoditelja

Napredna pretraga

Pregled bibliografske jedinice broj: 1282477

Medical treatment of acromegaly—experience from the Croatian acromegaly registry


Solak, Mirsala; Kraljević, Ivana; Popovac, Hrvoje; Šambula, Lana; Polovina, Tanja Škorić; Balaško, Annemarie; Tomšić, Karin Zibar; Dušek, Tina; Novak, Anela; Tripolski, Marija; Kaštelan, Darko
Medical treatment of acromegaly—experience from the Croatian acromegaly registry // Endocrine (Basingstoke) (2023) doi:10.1007/s12020-023-03430-7 (znanstveni, online first)


CROSBI ID: 1282477 Za ispravke kontaktirajte CROSBI podršku putem web obrasca

Naslov
Medical treatment of acromegaly—experience from the Croatian acromegaly registry

Autori
Solak, Mirsala ; Kraljević, Ivana ; Popovac, Hrvoje ; Šambula, Lana ; Polovina, Tanja Škorić ; Balaško, Annemarie ; Tomšić, Karin Zibar ; Dušek, Tina ; Novak, Anela ; Tripolski, Marija ; Kaštelan, Darko

Vrsta, podvrsta
Radovi u časopisima, znanstveni

Izvornik
Endocrine (Basingstoke) (2023)

Status rada
Online first

Ključne riječi
Acromegaly ; Biochemical control ; Medical treatment ; Pharmacotherapy ; Registry

Sažetak
PURPOSE: The aim of this study was to review therapeutic outcomes of the medical treatment of patients with acromegaly based on real-world data from the Croatian Acromegaly Registry. METHODS: In this retrospective study we investigated 163 patients (101 female, 62 male, age at diagnosis 47.2±13.4 years) treated between 1990 and 2020, of which 53 were treated medically (32.5%). The duration of follow-up was 115.8±304.4 months. The remission rate after the pituitary surgery was achieved in 66.5% (n=105/158 ; 5 patients refused surgery). Patients who did not achieve disease remission or had a relapse during follow-up (n=2), underwent reoperation (n=18/60, 30%) and/or radiotherapy (n=33/60, 55%) and/or medical treatment (n=53/60, 88.3%). One patient refused further treatment after the failure of the first pituitary surgery. RESULTS: Out of 53 patients treated with medical therapy, monotherapy was used in 34 (64.2%) and combination therapy in 19 (35.8%) patients. Remission (IGF-I<1.2 upper limit of normal, ULN) was achieved in 51 patients (96.2%). Out of 53 patients, 21 (39.6%) were treated with first-generation somatostatin receptor ligand (SRL-1) monotherapy, 10 (18.9%) with dopamine agonist (DA) monotherapy, one (1.9%) with pegvisomant monotherapy, 13 (24.4%) with a combination of SRL-1 and DA, three (5.7%) with a combination of SRL-1, DA and pegvisomant, two (3.8%) with a combination of second-generation somatostatin receptor ligand (SRL-2), DA and pegvisomant and in one (1.9%) temozolomide was added on top of SRL-1 and DA. Two patients currently have active disease, both on SRL-1 monotherapy, of whom one is non-adherent to the treatment. Radiotherapy was applied to 27 (50.9%) patients on medical therapy. CONCLUSION: Our results indicate that almost all patients with active acromegaly after pituitary surgery can achieve biochemical control with medical treatment.

Izvorni jezik
Engleski



POVEZANOST RADA


Profili:

Avatar Url Tina Dušek (autor)

Avatar Url Ivana Kraljević (autor)

Avatar Url Anela Novak (autor)

Avatar Url Darko Kaštelan (autor)

Poveznice na cjeloviti tekst rada:

doi

Citiraj ovu publikaciju:

Solak, Mirsala; Kraljević, Ivana; Popovac, Hrvoje; Šambula, Lana; Polovina, Tanja Škorić; Balaško, Annemarie; Tomšić, Karin Zibar; Dušek, Tina; Novak, Anela; Tripolski, Marija; Kaštelan, Darko
Medical treatment of acromegaly—experience from the Croatian acromegaly registry // Endocrine (Basingstoke) (2023) doi:10.1007/s12020-023-03430-7 (znanstveni, online first)
Solak, M., Kraljević, I., Popovac, H., Šambula, L., Polovina, T., Balaško, A., Tomšić, K., Dušek, T., Novak, A., Tripolski, M. & Kaštelan, D. (2023) Medical treatment of acromegaly—experience from the Croatian acromegaly registry. Prihvaćen za objavljivanje u Endocrine (Basingstoke). [Preprint] doi:10.1007/s12020-023-03430-7.
@unknown{unknown, author = {Solak, Mirsala and Kraljevi\'{c}, Ivana and Popovac, Hrvoje and \v{S}ambula, Lana and Polovina, Tanja \v{S}kori\'{c} and Bala\v{s}ko, Annemarie and Tom\v{s}i\'{c}, Karin Zibar and Du\v{s}ek, Tina and Novak, Anela and Tripolski, Marija and Ka\v{s}telan, Darko}, year = {2023}, DOI = {10.1007/s12020-023-03430-7}, keywords = {Acromegaly, Biochemical control, Medical treatment, Pharmacotherapy, Registry}, journal = {Endocrine (Basingstoke)}, doi = {10.1007/s12020-023-03430-7}, title = {Medical treatment of acromegaly—experience from the Croatian acromegaly registry}, keyword = {Acromegaly, Biochemical control, Medical treatment, Pharmacotherapy, Registry} }
@unknown{unknown, author = {Solak, Mirsala and Kraljevi\'{c}, Ivana and Popovac, Hrvoje and \v{S}ambula, Lana and Polovina, Tanja \v{S}kori\'{c} and Bala\v{s}ko, Annemarie and Tom\v{s}i\'{c}, Karin Zibar and Du\v{s}ek, Tina and Novak, Anela and Tripolski, Marija and Ka\v{s}telan, Darko}, year = {2023}, DOI = {10.1007/s12020-023-03430-7}, keywords = {Acromegaly, Biochemical control, Medical treatment, Pharmacotherapy, Registry}, journal = {Endocrine (Basingstoke)}, doi = {10.1007/s12020-023-03430-7}, title = {Medical treatment of acromegaly—experience from the Croatian acromegaly registry}, keyword = {Acromegaly, Biochemical control, Medical treatment, Pharmacotherapy, Registry} }

Časopis indeksira:


  • Current Contents Connect (CCC)
  • Web of Science Core Collection (WoSCC)
    • Science Citation Index Expanded (SCI-EXP)
    • SCI-EXP, SSCI i/ili A&HCI
  • Scopus
  • MEDLINE


Citati:





    Contrast
    Increase Font
    Decrease Font
    Dyslexic Font